Liat Vidal

4.7k total citations
82 papers, 3.1k citations indexed

About

Liat Vidal is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Liat Vidal has authored 82 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 26 papers in Pathology and Forensic Medicine and 23 papers in Hematology. Recurrent topics in Liat Vidal's work include Lymphoma Diagnosis and Treatment (25 papers), Neutropenia and Cancer Infections (16 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Liat Vidal is often cited by papers focused on Lymphoma Diagnosis and Treatment (25 papers), Neutropenia and Cancer Infections (16 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Liat Vidal collaborates with scholars based in Israel, Germany and United Kingdom. Liat Vidal's co-authors include Leonard Leibovici, Mical Paul, Anat Gafter‐Gvili, Hefziba Green, Ofer Shpilberg, Abigail Fraser, Pia Raanani, Ron Ram, Anat Stern and Sara Borok and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Liat Vidal

82 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liat Vidal Israel 29 1.1k 972 525 513 506 82 3.1k
Anna Candoni Italy 31 804 0.7× 955 1.0× 1.1k 2.2× 527 1.0× 926 1.8× 153 3.5k
Helmut Ostermann Germany 36 822 0.7× 1.4k 1.5× 893 1.7× 191 0.4× 808 1.6× 134 4.1k
Michael Kiehl Germany 34 907 0.8× 793 0.8× 1.4k 2.8× 533 1.0× 462 0.9× 87 3.6k
A. W. Dekker Netherlands 29 1.2k 1.1× 646 0.7× 1.5k 2.9× 400 0.8× 364 0.7× 66 3.0k
Michael Green United States 42 2.3k 2.1× 1.6k 1.6× 410 0.8× 568 1.1× 1.2k 2.3× 160 5.2k
Axel Glasmacher Germany 39 1.8k 1.6× 1.8k 1.8× 906 1.7× 628 1.2× 1.7k 3.3× 117 4.7k
R. De Bock Belgium 22 1.1k 1.0× 463 0.5× 930 1.8× 195 0.4× 261 0.5× 42 2.6k
Gerlinde Egerer Germany 41 1.4k 1.2× 927 1.0× 1.2k 2.4× 887 1.7× 677 1.3× 181 4.6k
George Mazariegos United States 59 1.1k 1.0× 1.8k 1.9× 342 0.7× 310 0.6× 337 0.7× 324 10.8k
Hartmut Link Germany 36 1.9k 1.7× 835 0.9× 2.4k 4.6× 410 0.8× 439 0.9× 142 5.1k

Countries citing papers authored by Liat Vidal

Since Specialization
Citations

This map shows the geographic impact of Liat Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liat Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liat Vidal more than expected).

Fields of papers citing papers by Liat Vidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liat Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liat Vidal. The network helps show where Liat Vidal may publish in the future.

Co-authorship network of co-authors of Liat Vidal

This figure shows the co-authorship network connecting the top 25 collaborators of Liat Vidal. A scholar is included among the top collaborators of Liat Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liat Vidal. Liat Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pasvolsky, Oren, et al.. (2018). Spontaneous Regression of Hodgkin Lymphoma: Case Report and Review of the Literature. Acta Haematologica. 141(1). 14–18. 3 indexed citations
2.
Vidal, Liat, et al.. (2017). Role of Induction Chemotherapy Prior to Chemoradiation in Head and Neck Squamous Cell Cancer—Systematic Review and Meta-analysis. The Cancer Journal. 23(2). 79–83. 20 indexed citations
3.
Yeshurun, Moshe, Iuliana Vaxman, Liat Shargian, et al.. (2017). Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study. Clinical Microbiology and Infection. 24(7). 749–754. 21 indexed citations
4.
Vidal, Liat, Ronit Gurion, Ron Ram, et al.. (2016). Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) – a systematic review and meta-analysis of randomized trials. Leukemia & lymphoma. 57(9). 2047–2057. 16 indexed citations
5.
Gafter‐Gvili, Anat, Elena Ribakovsky, Abraham Avigdor, et al.. (2015). Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study. Leukemia & lymphoma. 57(1). 63–69. 23 indexed citations
6.
Vaxman, Iuliana, Ron Ram, Anat Gafter‐Gvili, et al.. (2015). Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis. Bone Marrow Transplantation. 50(5). 706–714. 22 indexed citations
7.
8.
9.
Ben‐Aharon, Irit, et al.. (2013). The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review. PLoS ONE. 8(1). e51780–e51780. 63 indexed citations
10.
Muchtar, Eli, Mordechai R. Kramer, Liat Vidal, et al.. (2013). Posttransplantation Lymphoproliferative Disorder in Lung Transplant Recipients. Transplantation. 96(7). 657–663. 14 indexed citations
11.
Ram, Ron, L. Farbman, Leonard Leibovici, et al.. (2012). Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients. International Journal of Antimicrobial Agents. 40(2). 123–126. 20 indexed citations
12.
Ram, Ron, Anat Gafter‐Gvili, Liat Vidal, et al.. (2010). Management of adult patients with acute lymphoblastic leukemia in first complete remission. Cancer. 116(14). 3447–3457. 53 indexed citations
13.
Vidal, Liat, Anat Gafter‐Gvili, Leonard Leibovici, et al.. (2009). Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials. JNCI Journal of the National Cancer Institute. 101(4). 248–255. 207 indexed citations
14.
15.
Vidal, Liat, et al.. (2009). 5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome - a systematic review and meta-analysis. Haematologica. 95(2). 303–310. 77 indexed citations
16.
Vidal, Liat, Anat Gafter‐Gvili, Sara Borok, et al.. (2007). Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy. 60(2). 247–257. 108 indexed citations
17.
Green, Hefziba, Mical Paul, Liat Vidal, & Leonard Leibovici. (2007). Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database of Systematic Reviews. CD005590–CD005590. 110 indexed citations
18.
Green, Hefziba, Mical Paul, Liat Vidal, & Leonard Leibovici. (2007). Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials. Mayo Clinic Proceedings. 82(9). 1052–1059. 264 indexed citations
19.
Paul, Mical, Sara Borok, Abigail Fraser, Liat Vidal, & Leonard Leibovici. (2005). Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy. 55(4). 436–444. 73 indexed citations
20.
Paul, Mical, Sara Borok, Abigail Fraser, et al.. (2005). Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients. Cochrane Database of Systematic Reviews. CD003914–CD003914. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Candoni Breakdown of academic impact, for papers by Helmut Ostermann Breakdown of academic impact, for papers by Michael Kiehl Breakdown of academic impact, for papers by A. W. Dekker Breakdown of academic impact, for papers by Michael Green Breakdown of academic impact, for papers by Axel Glasmacher Breakdown of academic impact, for papers by R. De Bock Breakdown of academic impact, for papers by Gerlinde Egerer Breakdown of academic impact, for papers by George Mazariegos Breakdown of academic impact, for papers by Hartmut Link
Rankless by CCL
2026